277 related articles for article (PubMed ID: 22477390)
1. Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.
Kamath AR; Pai RG
Int J Angiol; 2008; 17(2):63-70. PubMed ID: 22477390
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a) and calcific aortic valve stenosis: A systematic review.
Guddeti RR; Patil S; Ahmed A; Sharma A; Aboeata A; Lavie CJ; Alla VM
Prog Cardiovasc Dis; 2020; 63(4):496-502. PubMed ID: 32526213
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells.
Choi B; Lee S; Kim SM; Lee EJ; Lee SR; Kim DH; Jang JY; Kang SW; Lee KU; Chang EJ; Song JK
Circulation; 2017 May; 135(20):1935-1950. PubMed ID: 28179397
[TBL] [Abstract][Full Text] [Related]
4. Valvular Calcification in Chronic Kidney Disease.
Brandenburg VM; Schuh A; Kramann R
Adv Chronic Kidney Dis; 2019 Nov; 26(6):464-471. PubMed ID: 31831124
[TBL] [Abstract][Full Text] [Related]
5. The lipid theory in the pathogenesis of calcific aortic stenosis.
Parisi V; Leosco D; Ferro G; Bevilacqua A; Pagano G; de Lucia C; Perrone Filardi P; Caruso A; Rengo G; Ferrara N
Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):519-25. PubMed ID: 25816732
[TBL] [Abstract][Full Text] [Related]
6. Current Evidence and Future Perspectives on Pharmacological Treatment of Calcific Aortic Valve Stenosis.
Donato M; Ferri N; Lupo MG; Faggin E; Rattazzi M
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158204
[TBL] [Abstract][Full Text] [Related]
7. Aortic Valve Replacement for Moderate Aortic Stenosis with Severe Calcification and Left Ventricualr Dysfunction-A Case Report and Review of the Literature.
Narang N; Lang RM; Liarski VM; Jeevanandam V; Hofmann Bowman MA
Front Cardiovasc Med; 2017; 4():14. PubMed ID: 28396860
[TBL] [Abstract][Full Text] [Related]
8. Severe valvular heart disease in patients on chronic dialysis. A five-year multicenter French survey.
Baglin A; Hanslik T; Vaillant JN; Boulard JC; Moulonguet-Doleris L; Prinseau J
Ann Med Interne (Paris); 1997; 148(8):521-6. PubMed ID: 9538397
[TBL] [Abstract][Full Text] [Related]
9. Contribution of Oxidative Stress (OS) in Calcific Aortic Valve Disease (CAVD): From Pathophysiology to Therapeutic Targets.
Tanase DM; Valasciuc E; Gosav EM; Floria M; Costea CF; Dima N; Tudorancea I; Maranduca MA; Serban IL
Cells; 2022 Aug; 11(17):. PubMed ID: 36078071
[TBL] [Abstract][Full Text] [Related]
10. Oxidative Stress in Calcific Aortic Valve Stenosis: Protective Role of Natural Antioxidants.
Adhikari R; Shiwakoti S; Ko JY; Dhakal B; Park SH; Choi IJ; Kim HJ; Oak MH
Antioxidants (Basel); 2022 Jun; 11(6):. PubMed ID: 35740065
[TBL] [Abstract][Full Text] [Related]
11. Targeting vasoactive peptides for managing calcific aortic valve disease.
Peltonen T; Ohukainen P; Ruskoaho H; Rysä J
Ann Med; 2017 Feb; 49(1):63-74. PubMed ID: 27585243
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-β1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model.
Jenke A; Kistner J; Saradar S; Chekhoeva A; Yazdanyar M; Bergmann AK; Rötepohl MV; Lichtenberg A; Akhyari P
Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1123-H1141. PubMed ID: 32986963
[TBL] [Abstract][Full Text] [Related]
13. Calcific Aortic Valve Disease-Natural History and Future Therapeutic Strategies.
Alushi B; Curini L; Christopher MR; Grubitzch H; Landmesser U; Amedei A; Lauten A
Front Pharmacol; 2020; 11():685. PubMed ID: 32477143
[TBL] [Abstract][Full Text] [Related]
14. Multi-Omics Approaches to Define Calcific Aortic Valve Disease Pathogenesis.
Blaser MC; Kraler S; Lüscher TF; Aikawa E
Circ Res; 2021 Apr; 128(9):1371-1397. PubMed ID: 33914608
[TBL] [Abstract][Full Text] [Related]
15. Osseous and chondromatous metaplasia in calcific aortic valve stenosis.
Torre M; Hwang DH; Padera RF; Mitchell RN; VanderLaan PA
Cardiovasc Pathol; 2016; 25(1):18-24. PubMed ID: 26386747
[TBL] [Abstract][Full Text] [Related]
16. Medical therapy for rheumatic heart disease: is it time to be proactive rather than reactive?
Rajamannan NM; Antonini-Canterin F; Moura L; Zamorano JL; Rosenhek RA; Best PJ; Lloyd MA; Rocha-Goncalves F; Chandra S; Alfieri O; Lancellotti P; Tornos P; Baliga RR; Wang A; Bashore T; Ramakrishnan S; Spargias K; Shuvy M; Beeri R; Lotan C; Suwaidi JA; Bahl V; Pierard LA; Maurer G; Nicolosi GL; Rahimtoola SH; Chopra K; Pandian NG
Indian Heart J; 2009; 61(1):14-23. PubMed ID: 19729684
[TBL] [Abstract][Full Text] [Related]
17. Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention.
Parolari A; Loardi C; Mussoni L; Cavallotti L; Camera M; Biglioli P; Tremoli E; Alamanni F
Eur J Cardiothorac Surg; 2009 Mar; 35(3):493-504. PubMed ID: 19162497
[TBL] [Abstract][Full Text] [Related]
18. Systemic and local levels of fetuin-A in calcific aortic valve stenosis.
Kaden JJ; Reinöhl JO; Blesch B; Brueckmann M; Haghi D; Borggrefe M; Schmitz F; Klomfass S; Pillich M; Ortlepp JR
Int J Mol Med; 2007 Aug; 20(2):193-7. PubMed ID: 17611637
[TBL] [Abstract][Full Text] [Related]
19. [Statins in aortic stenosis].
Dejanović J; Ivanov I
Med Pregl; 2009; 62 Suppl 3():101-4. PubMed ID: 19702126
[TBL] [Abstract][Full Text] [Related]
20. Valvular heart disease: the influence of changing etiology on nosology.
Boudoulas H; Vavuranakis M; Wooley CF
J Heart Valve Dis; 1994 Sep; 3(5):516-26. PubMed ID: 8000586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
